ERBB2 and breast cancer: Importantly, the observed role of α3β1 in HER2-driven mammary tumorigenesis was not observed in triple-negative MDA-MB-231 cells, where the downregulation of α3β1 resulted in the opposite effect on invasiveness, which clearly demonstrates the tumor type-specific function of α3β1 in breast cancer.